Effect of silibinin on the growth and progression of primary lung tumors in mice. (Q48689670)

14 February 2018

title

Effect of silibinin on the growth and progression of primary lung tumors in mice. (English)

1 reference

14 February 2018

author

Rana P. Singh

1

1 reference

14 February 2018

author name string

Gagan Deep

2

1 reference

14 February 2018

Manesh Chittezhath

3

1 reference

14 February 2018

Manjinder Kaur

4

1 reference

14 February 2018

Lori D Dwyer-Nield

5

1 reference

14 February 2018

Alvin M Malkinson

6

1 reference

14 February 2018

Rajesh Agarwal

7

1 reference

14 February 2018

language of work or name

English

0 references

publication date

1 June 2006

1 reference

14 February 2018

Journal of the National Cancer Institute

published in

1 reference

14 February 2018

volume

98

1 reference

14 February 2018

page(s)

846-855

1 reference

14 February 2018

issue

12

1 reference

14 February 2018

Tobacco and the global lung cancer epidemic

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

21 January 2018

Cancer statistics, 2005

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Tumor dormancy in vivo by prevention of neovascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Angiogenesis in cancer and other diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Activation of the Ki-ras protooncogene in spontaneously occurring and chemically induced lung tumors of the strain A mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Association of chromosome 12p genetic polymorphisms with lung adenocarcinoma risk and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Chemoprevention of lung cancer--from biology to clinical reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Silymarin: a review of its clinical properties in the management of hepatic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Silibinin protects against photocarcinogenesis via modulation of cell cycle regulators, mitogen-activated protein kinases, and Akt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Oral silibinin inhibits lung tumor growth in athymic nude mice and forms a novel chemocombination with doxorubicin targeting nuclear factor kappaB-mediated inducible chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Differential expression of inducible nitric oxide synthase and peroxisome proliferator-activated receptor gamma in non-small cell lung carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Tissue distribution of silibinin, the major active constituent of silymarin, in mice and its association with enhancement of phase II enzymes: implications in cancer chemoprevention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Primary lung tumors in mice as an aid for understanding, preventing, and treating human adenocarcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Proliferating cell nuclear antigen (PCNA/cyclin) immunocytochemistry as a labeling index in mouse lung tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Cyclin D1 as a proliferative marker regulating retinoblastoma phosphorylation in mouse lung epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Targeting angiogenesis: a review of angiogenesis inhibitors in the treatment of lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Vascular endothelial growth factor receptor-1 modulates vascular endothelial growth factor-mediated angiogenesis via nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Cyclooxygenase as a target in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Chemoprotective effect of plant phenolics against anthracycline-induced toxicity on rat cardiomyocytes. Part I. Silymarin and its flavonolignans

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Silymarin protects dopaminergic neurons against lipopolysaccharide-induced neurotoxicity by inhibiting microglia activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Silibinin protects against cisplatin-induced nephrotoxicity without compromising cisplatin or ifosfamide anti-tumour activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Increased level of exhaled nitric oxide and up-regulation of inducible nitric oxide synthase in patients with primary lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

Nitric oxide promotes proliferation and plasminogen activator production by coronary venular endothelium through endogenous bFGF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJJ231

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJJ231

1 reference

14 February 2018

PubMed ID

16788158

1 reference

14 February 2018